178 related articles for article (PubMed ID: 25996952)
41. Significance of oncogenes and tumor suppressor genes in AML prognosis.
Kavianpour M; Ahmadzadeh A; Shahrabi S; Saki N
Tumour Biol; 2016 Aug; 37(8):10041-52. PubMed ID: 27179964
[TBL] [Abstract][Full Text] [Related]
42. Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.
Masetti R; Bertuccio SN; Astolfi A; Chiarini F; Lonetti A; Indio V; De Luca M; Bandini J; Serravalle S; Franzoni M; Pigazzi M; Martelli AM; Basso G; Locatelli F; Pession A
J Hematol Oncol; 2017 Jan; 10(1):26. PubMed ID: 28109323
[TBL] [Abstract][Full Text] [Related]
43. [Advance of study on MN1 gene in acute myeloid leukemia - review].
Sun HM; Qian SX; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):504-8. PubMed ID: 19379599
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically downregulating MTSS1 through DNMT3B.
Li XD; Zhang JX; Jiang LJ; Wang FW; Liu LL; Liao YJ; Jin XH; Chen WH; Chen X; Guo SJ; Zhou FJ; Zeng YX; Guan XY; Liu ZW; Xie D
Oncogene; 2016 Dec; 35(49):6281-6292. PubMed ID: 27181205
[TBL] [Abstract][Full Text] [Related]
45. Trisomy 13 correlates with RUNX1 mutation and increased FLT3 expression in AML-M0 patients.
Silva FP; Lind A; Brouwer-Mandema G; Valk PJ; Giphart-Gassler M
Haematologica; 2007 Aug; 92(8):1123-6. PubMed ID: 17650443
[TBL] [Abstract][Full Text] [Related]
46. A novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia.
Jiang X; Sun L; Qiu JJ; Sun X; Li S; Wang X; So CW; Dong S
PLoS One; 2013; 8(8):e72335. PubMed ID: 23951311
[TBL] [Abstract][Full Text] [Related]
47. EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer.
Kedmi M; Ben-Chetrit N; Körner C; Mancini M; Ben-Moshe NB; Lauriola M; Lavi S; Biagioni F; Carvalho S; Cohen-Dvashi H; Schmitt F; Wiemann S; Blandino G; Yarden Y
Sci Signal; 2015 Mar; 8(368):ra29. PubMed ID: 25783158
[TBL] [Abstract][Full Text] [Related]
48. Effect of metastasis suppressor 1 on H1299 cells and its clinical significance in non-small cell lung cancer.
Zhao H; Xue J; Liu J; Liu Y; Cheng Y
Oncol Rep; 2016 Nov; 36(5):2814-2822. PubMed ID: 27634022
[TBL] [Abstract][Full Text] [Related]
49. Homeobox gene expression in acute myeloid leukemia is linked to typical underlying molecular aberrations.
Skvarova Kramarzova K; Fiser K; Mejstrikova E; Rejlova K; Zaliova M; Fornerod M; Drabkin HA; van den Heuvel-Eibrink MM; Stary J; Trka J; Starkova J
J Hematol Oncol; 2014 Dec; 7():94. PubMed ID: 25539595
[TBL] [Abstract][Full Text] [Related]
50. Expression and Significances of MTSS1 in Pancreatic Cancer.
Zhou L; Li J; Shao QQ; Guo JC; Liang ZY; Zhou WX; Zhang TP; You L; Zhao YP
Pathol Oncol Res; 2016 Jan; 22(1):7-14. PubMed ID: 26198729
[TBL] [Abstract][Full Text] [Related]
51. MTSS1 suppresses cell migration and invasion by targeting CTTN in glioblastoma.
Zhang S; Qi Q
J Neurooncol; 2015 Feb; 121(3):425-31. PubMed ID: 25385572
[TBL] [Abstract][Full Text] [Related]
52. Identification of RHOBTB2 aberration as an independent prognostic indicator in acute myeloid leukemia.
Liu P; Ma Q; Chen H; Zhang L; Zhang X
Aging (Albany NY); 2021 Jun; 13(11):15269-15284. PubMed ID: 34074803
[TBL] [Abstract][Full Text] [Related]
53. Macrocalyxin A inhibits proliferation and induces apoptosis of t (8;21) leukemia cells through mitochondrial signaling pathways and regulates AML-ETO mRNA expression.
Wang Z; Lv Y; Xia J; Shi H; Wang W; Zhou Y
Mol Med Rep; 2015 Sep; 12(3):3537-3542. PubMed ID: 26016618
[TBL] [Abstract][Full Text] [Related]
54. p63 controls cell migration and invasion by transcriptional regulation of MTSS1.
Giacobbe A; Compagnone M; Bongiorno-Borbone L; Antonov A; Markert EK; Zhou JH; Annicchiarico-Petruzzelli M; Melino G; Peschiaroli A
Oncogene; 2016 Mar; 35(12):1602-8. PubMed ID: 26119942
[TBL] [Abstract][Full Text] [Related]
55. KDM3B shows tumor-suppressive activity and transcriptionally regulates HOXA1 through retinoic acid response elements in acute myeloid leukemia.
Xu X; Nagel S; Quentmeier H; Wang Z; Pommerenke C; Dirks WG; Macleod RAF; Drexler HG; Hu Z
Leuk Lymphoma; 2018 Jan; 59(1):204-213. PubMed ID: 28540746
[TBL] [Abstract][Full Text] [Related]
56. MTSS1: a multifunctional protein and its role in cancer invasion and metastasis.
Xie F; Ye L; Ta M; Zhang L; Jiang WG
Front Biosci (Schol Ed); 2011 Jan; 3(2):621-31. PubMed ID: 21196400
[TBL] [Abstract][Full Text] [Related]
57. Metastasis suppressor 1 (MTSS1) expression is associated with reduced in-vivo metastasis and enhanced patient survival in lung adenocarcinoma.
Taylor MD; Bollt O; Iyer SC; Robertson GP
Clin Exp Metastasis; 2018 Feb; 35(1-2):15-23. PubMed ID: 29218652
[TBL] [Abstract][Full Text] [Related]
58. STAT3β is a tumor suppressor in acute myeloid leukemia.
Aigner P; Mizutani T; Horvath J; Eder T; Heber S; Lind K; Just V; Moll HP; Yeroslaviz A; Fischer MJM; Kenner L; Győrffy B; Sill H; Grebien F; Moriggl R; Casanova E; Stoiber D
Blood Adv; 2019 Jul; 3(13):1989-2002. PubMed ID: 31270081
[TBL] [Abstract][Full Text] [Related]
59. Developmental expression and differentiation-related neuron-specific splicing of metastasis suppressor 1 (Mtss1) in normal and transformed cerebellar cells.
Glassmann A; Molly S; Surchev L; Nazwar TA; Holst M; Hartmann W; Baader SL; Oberdick J; Pietsch T; Schilling K
BMC Dev Biol; 2007 Oct; 7():111. PubMed ID: 17925019
[TBL] [Abstract][Full Text] [Related]
60. MN1, a novel player in human AML.
Grosveld GC
Blood Cells Mol Dis; 2007; 39(3):336-9. PubMed ID: 17698380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
